Nature Communications (Jan 2022)

Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

  • Mathieu Claireaux,
  • Rémy Robinot,
  • Jérôme Kervevan,
  • Mandar Patgaonkar,
  • Isabelle Staropoli,
  • Anne Brelot,
  • Alexandre Nouël,
  • Stacy Gellenoncourt,
  • Xian Tang,
  • Mélanie Héry,
  • Stevenn Volant,
  • Emeline Perthame,
  • Véronique Avettand-Fenoël,
  • Julian Buchrieser,
  • Thomas Cokelaer,
  • Christiane Bouchier,
  • Laurence Ma,
  • Faroudy Boufassa,
  • Samia Hendou,
  • Valentina Libri,
  • Milena Hasan,
  • David Zucman,
  • Pierre de Truchis,
  • Olivier Schwartz,
  • Olivier Lambotte,
  • Lisa A. Chakrabarti

DOI
https://doi.org/10.1038/s41467-022-28130-0
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 19

Abstract

Read online

Here, Claireaux et al. show that people who naturally control HIV infection express lower levels of the viral co-receptor CCR5 in specific CD4+ T cells, and that this results from mutations or receptor internalization by CD4+ T cell-produced chemokines.